Lamotrigine treatment reverses depressive-like behavior and alters BDNF levels in the brains of maternally deprived adult rats  by Abelaira, Helena M. et al.
Pharmacology, Biochemistry and Behavior 101 (2012) 348–353
Contents lists available at SciVerse ScienceDirect
Pharmacology, Biochemistry and Behavior
j ourna l homepage: www.e lsev ie r .com/ locate /pharmbiochembehLamotrigine treatment reverses depressive-like behavior and alters BDNF levels in
the brains of maternally deprived adult rats
Helena M. Abelaira a, Gislaine Z. Réus a, Karine F. Ribeiro a, Giovanni Zappellini a, Andreza L. Cipriano a,
Giselli Scaini b, Emilio L. Streck b, João Quevedo a,⁎
a Laboratório de Neurociências and Instituto Nacional de Ciência e Tecnologia Translacional em Medicina (INCT-TM), Programa de Pós-Graduação em Ciências da Saúde,
Unidade Acadêmica de Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806-000, Criciúma, SC, Brazil
b Laboratório de Bioenergética and Instituto Nacional de Ciência e Tecnologia Translacional em Medicina (INCT-TM), Programa de Pós-Graduação em Ciências da Saúde,
Unidade Acadêmica de Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806-000, Criciúma, SC, BrazilAbbreviations: BDNF, brain-derived neurotrophic fac
NMDA, N-methyl-D-aspartate.
⁎ Corresponding author at: Laboratório de Neurociênc
emCiências da Saúde, Unidade Acadêmica de Ciências da S
Sul Catarinense, 88806-000 Criciúma, SC, Brazil. Fax: +55
E-mail address: quevedo@unesc.net (J. Quevedo).
0091-3057 © 2012 Elsevier Inc.
doi:10.1016/j.pbb.2012.01.019
Open access under the Elsea b s t r a c ta r t i c l e i n f oArticle history:
Received 9 September 2011
Received in revised form 18 January 2012
Accepted 22 January 2012
Available online 27 January 2012
Keywords:
Lamotrigine
BDNF
NGF
Maternal deprivation
DepressionLamotrigine is an anticonvulsant and has an antiglutamatergic action,whichmay contribute to its antidepressant
effects, since glutamate has been linked to depression. The purpose of the present study was to investigate the
behavioral and molecular effects of lamotrigine treatment in maternally deprived rats. To this aim, deprived
and non-deprived male rats were treated with lamotrigine (20 mg/kg) once a day for 14 days during their
adult phase. Their behavior was then assessed in the forced swimming and open ﬁeld tests. In addition to this,
the BDNF and NGF levels were assessed in the prefrontal cortex, hippocampus and amygdala. In the course of
this study we demonstrated that maternally deprived rats treated with saline and lamotrigine showed an in-
crease in their immobility time and a decrease in the climbing and swimming times when compared with
non-deprived rats treatedwith saline alone. Treatment with lamotrigine reversed the increase in the immobility
time in the deprived rats. The BDNF levels were decreased in the amygdala in deprived rats treated with saline,
and treatment with lamotrigine reversed this decrease. The NGF levels were decreased in the hippocampus in
deprived rats treated with saline, but treatment with lamotrigine did not reverse this decrease. In conclusion,
lamotrigine showed antidepressant effects in the forced swimming test, and it presented positive effects on
the BDNF protein levels in the amygdala of maternally deprived rats.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Depression is one of themost prevalent and costly psychopathologies
and is globally accepted as a leading cause of morbidity and mortality
(Pacher andUngvari, 2001). There aremany symptoms that are included
in major depression, but the more frequent symptoms are: depressed
mood, anhedonia, irritability, difﬁculties in concentrating, and abnor-
malities in appetite and sleep (Nestler et al., 2002).
Preclinical studies have provided direct evidence that early life
stress leads to a heightened responsiveness to stress and alterations
in the hypothalamic–pituitary–adrenal system throughout the life-
span (Heim and Nemeroff, 2001). Among the paradigms used to
study early adverse life events, long maternal separation in rodents
mimics the early life neglect/loss of parents in humans and has
been presented as one of the most potent natural stressors duringtor; NGF, nerve growth factor;
ias, Programa de Pós-Graduação
aúde, Universidade do Extremo
48 3431 2736.
vier OA license.development. Maternal separation has been developed to examine
the consequences of early adverse experiences on behavior and neu-
robiology. This model has been described as a model of vulnerability
to drug dependence, anxiety, stress-induced illness and depression
(Hall, 1998; Francis et al., 1999).
The treatment of depression is based on the monoaminergic system.
Classic antidepressants act on themodulation of this system by inhibiting
the reuptake of neurotransmitters, increasing their concentrations in the
synaptic cleft (Schmidt et al., 2008). The major shortcomings in treating
these disorders with antidepressants are that the therapeutic response
develops slowly (over 3–4 wks), there are often side effects and there
are a signiﬁcant percentage (30%) of non-responders (Wong and Licinio,
2001). Thus, it is necessary to identify and develop alternative therapeutic
options for the treatment of major depression.
Lamotrigine is an anticonvulsant belonging to the class of inhibitors
that act on the sodium channels. It is one of themost widely used drugs
in bipolar disorder and is widely used to control the depressive symp-
toms associated with bipolar disorder (Calabrese et al., 2003). Also, its
effectiveness in the treatment of depression was highlighted in a ran-
domized, double blind study (Thomas et al., 2010). The anticonvulsant
action of lamotrigine is facilitated by reducing the neuronal excitability
through the inhibition of the sodium channels, preventing their return
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This effect on the sodium channels results in a decreased release of glu-
tamate (Waldmeier et al., 1996), which is involved in the pathogenesis
of depression. The effect of lamotrigine on the 5-HT1A receptors in
healthy humanmales is measured using body temperature and plasma
cortisol as an index of 5-HT1A receptor function (Shiah et al., 1998). In
vitro, using human platelets and rat brain synaptosomes, lamotrigine
inhibits the uptake of 5-HT, dopamine and noredrenaline in a manner
that appeared to be independent of any effect on the sodium channels
(Southam et al., 1998). Lamotrigine does not exhibit a high afﬁnity in
binding to the following neurotransmitter receptors: adenosine A1
and A2; adrenergic α1, α2, and β; dopamine D1 and D2; γ-
aminobutyric acid (GABA) A andB; histamineH1; kappa opioid;musca-
rinic acetylcholine; and serotonin 5-HT2 (Leach et al., 1991).
The antiglutamatergic action of lamotrigine may also contribute to
its antidepressant effect (Ketter and Wang, 2003), since glutamate
has been linked to depression (Tokita et al., 2011), and that glutamate
receptor antagonists like N-methyl-aspartate (NMDA) have shown
antidepressant-like effects in animal models of depression (Réus
et al., 2010, 2011a).
The precise molecular mechanisms responsible for the antidepres-
sant action of lamotrigine are still not fully understood. However, evi-
dence suggests that a variety of intracellular pathways and signal
transduction cascades are involved in both the pathophysiology and
treatment of depression (Coyle and Duman, 2003; Duman, 1998;
Duman et al., 1997; Vaidya et al., 2007). Many antidepressant drugs
acutely increase monoamine levels, but the requirement for chronic
treatment has led to the hypothesis that long-term adaptations are nec-
essary for the therapeutic actions of these treatments (Duman et al.,
1994). Several studies have pointed to the role of brain-derived-
neurotrophic factor (BDNF) and the nerve growth factor (NGF) in
major depression. Decreased levels of BDNF and NGF have been
shown in animal models of depression and humans with depression
(Karege et al., 2005). Conversely, administration of antidepressant
drugs increases BDNF and NGF expression (Nibuya et al., 1995).
Studies linking the effects of lamotrigine on behavior and neurotro-
phin levels in the brain tissue of maternally deprived rats have not
been characterized. So, the present study was aimed to investigate the
behavioral and physiological effects of the administration of lamotrigine
onmaternal deprivation in rats. The behavioral effects were evaluated in
the open ﬁeld test and forced swimming tests. Additionally, BDNF and
NGF protein levels were assessed in the prefrontal cortex, hippocampus
and amygdala.
2. Material and methods
2.1. Animals
Pregnant femaleWistar rats (age of 3 months, weight of 250–280 g)
were obtained from the UNESC (Universidade do Extremo Sul Catari-
nense, Criciúma, SC, Brazil) breeding colony. All animals were
maintained on a 12-h light/dark cycle (lights on at 7:00 a.m.). The
environment temperature (±22 °C) was kept constant. Pregnant fe-
males were individually housed with sawdust bedding and ad libitum
access to food and water. Litters were culled to eight pups per dam,
four males and four females. The day of delivery was marked as day
zero, and on post natal day 1 (PND-1) a maternal deprivation protocol
was applied to 50% of the male pups from days 1–10 after birth; the
other males were used as controls. The animals were weaned at the
age of 21 days, and housed in regular cages, with 5 animals to a cage.
Femaleswere donated to theUNESC colony for other researchpurposes.
The males were used in the present experiments. There were two ex-
perimental groups: (1) control (non-deprived), which received no
treatment whatsoever; (2) deprived, which were submitted to mater-
nal deprivation as described. All experimental procedures involving
animals were performed in accordance with the NIH Guide for theCare and Usage of Laboratory Animals and the Brazilian Society for
Neuroscience and Behavior (SBNeC) recommendations for animal care
and with approval by local Ethics Committee under protocol number
01/2011.
2.2. Maternal deprivation protocol
Pregnant Female Wistar rats were maintained in individual cages
until the delivery day. Deprivation was carried out for 180 min a
day from PND-01 to PND-10 according to previous studies (Réus
et al., 2001b; Mello, 2009). The deprivation protocol consisted of: re-
moving the mother from the residence cage and taking her to another
room. Pups were maintained in their home cages (grouped in the nest
in the presence of maternal odor). We prefer this maternal depriva-
tion protocol because it does not require manipulation of the pups
(Mello, 2009; Kosten et al., 2007). At the end of each daily deprivation
session, the mothers were returned to their home cages; this proce-
dure was carried out during the light part of the cycle, between
8:00 a.m. and 2:00 p.m. Control rats remained in their resident
cages together with their mothers throughout. Only after PND-11
were the cages cleaned normally again, according to the standard lab-
oratory routine. On PND-21 the animals were weaned, and the males
were maintained in groups of 4, in 50×25×40 cm plastic cages with a
stainless steel lid, having food and water available ad libitum, as per
all the other animals in our animal housing facility.
2.3. Drugs and treatment
Lamotrigine was obtained from Sigma (Brazil) and a dose of
20 mg/kg was injected intraperitoneally once a day over 14 days,
after the animals had reached the age of 3 months. The dose was
based on previous studies (Kaster et al., 2007). The treatments were
administrated in a volume of 1 ml/kg. Lamotrigine was diluted in a sa-
line solution (NaCl 0.9% w/v) and control groups received saline solu-
tion alone. Adult animals were randomly divided into deprived and
non-deprived groups before the start of treatment. To develop this
study we employed 60 animals (n=15 each) separated in four groups,
as follows: (1) non-deprived+saline; (2) non-deprived+lamotrigine;
(3) deprived+saline; (4) deprived+lamotrigine. The behavior of the
animalswas evaluated 1 h after the administration of the each injection.
2.4. Open-ﬁeld test
This apparatus consists of a 45×60 cm brown plywood arena sur-
rounded by 50 cm high wooden walls and containing a frontal glass
wall. The ﬂoor of the open ﬁeld was divided into nine rectangles
(15×20 cm each) via black lines. Animals were gently placed on the
left rear quadrant, and left to explore the arena. On the 12th day of
chronic treatment, the rats were exposed to the open-ﬁeld apparatus.
The number of horizontal (crossings) and vertical (rearings) activities
performed by each rat during the 5 min observation period were
counted by an expert observer, in order to assess any possible effects
on spontaneous locomotor activity.
2.5. Forced swimming test
The forced swimming test was conducted according to previous
reports (Detke et al., 1995; Garcia et al., 2008a, 2008b; Porsolt et al.,
1977). The test involves two individual exposures to a cylindrical
tank ﬁlled with water, in which the rats cannot touch the bottom of
the tank or escape. The tank is made of transparent Plexiglas, 80 cm
tall, 30 cm in diameter, and ﬁlled with water (22–23 °C) to a depth
of 40 cm. On the 13th day of chronic treatment with lamotrigine,
1 h after the administration of the drug treatment, the rats were indi-
vidually placed in the cylinder containing water for 15 min (pre-test
session). On the 14th day, the rats received the last intraperitoneal
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Fig. 1. The effects of the administration of lamotrigine on an animalmodel of depression on
the immobility time, climbing time and swimming time (1A) of rats subjected to the forced
swimming test and on the number of crossings and rearings (1B) of rats subjected to the
open ﬁeld test. Bars represent means±S.E.M. (n=15–18). *pb0.05 vs. non-deprived+sa-
line; and #pb0.05 vs. deprived+saline according to one-way ANOVA followed by Tukey
post-hoc test.
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swimming test for a 5 min session (test session) and the immobility,
climbing and swimming time of the rats were recorded in seconds.
After the conclusion of the behavioral tests, all rats were killed by de-
capitation, and the skulls were immediately removed. The prefrontal
cortex, hippocampus and amygdala were quickly isolated by hand
dissection using a magnifying glass and a thin brush, the dissection
being based on the histological distinctions described by Paxinos
and Watson (1986).
2.6. Neurotrophins measurement
The BDNF and NGF levels in the prefrontal cortex, hippocampus
and amygdala were measured by sandwich-ELISA, according to the
manufacturer's instructions (Chemicon, USA for BDNF and Millipore,
USA & Canada for NGF). Brieﬂy, the rat's prefrontal cortex, hippocam-
pus and amygdala were homogenized in a phosphate buffer solution
(PBS) with a protease inhibitor cocktail (Sigma). Microtiter plates
(96-well ﬂat-bottom) were coated for 24 h with the samples diluted
1:2 in sample diluent with the standard curve ranging from 7.8 to
500 pg/ml of BNDF and NGF. The plates were then washed with sam-
ple diluent and a monoclonal anti-BNDF for a total of four times, and
an anti-NGF rabbit antibody (diluted 1:1000 in sample diluent) was
added to each well and incubated for 3 h at room temperature.
After washing, a peroxidase conjugated anti-rabbit antibody (diluted
1:1000) was added to each well and incubated at room temperature
for 1 h. After the addition of the streptavidin–enzyme, substrate and
stop solutions, the amount of each neurotrophin was determined by
absorbance at 450 nm. The standard curve demonstrates a direct rela-
tionship between Optical Density (OD) and the concentration. Total
protein was measured utilizing Lowry's method using bovine serum
albumin as a standard, as previously described by Lowry et al. (1951).
2.7. Statistical analysis
All data is presented as mean±S.E.M. Differences among experi-
mental groups in the forced swimming and open ﬁeld tests, and in
the assessment of BDNF and NGF levels were determined by one-
way ANOVA, followed by the Tukey post-hoc test when ANOVA was
signiﬁcant; p valuesb0.05 were considered to be statistical signiﬁcant.
3. Results
The effects of the administration of lamotrigine on immobility,
climbing and swimming times are illustrated in Fig. 1A. In deprived
rats treated with saline we observed an increase in the immobility
time (pb0.001; Fig. 1A) and a decrease in the climbing and swimming
time (pb0.001; Fig. 1A), compared with non-deprived rats treated
with saline. The treatment with lamotrigine reversed the increase in
the immobility time (pb0.001; Fig. 1A) in deprived rats. The non-
deprived groups did not differ signiﬁcantly. Interestingly, in the
open-ﬁeld test, the treatment with lamotrigine did not modify the
number of crossings (p=0.78; Fig. 1B) and rearings (p=0.51; Fig. 1B)
in any of the groups.
The effects of the administration of lamotrigine on BDNF and NGF
levels in the rat's prefrontal cortex, hippocampus and amygdala are
shown in Fig. 2. The BDNF levels were decreased in the amygdala
(pb0.021; Fig. 2A) in deprived rats treated with saline, and treatment
with lamotrigine changed this decrease. In the prefrontal cortex
(p=0.97; Fig. 2A) and hippocampus (p=0.233; Fig. 2A), treatment
with lamotrigine in rats did not alter the BDNF protein levels. The
NGF levels were decreased in the hippocampus (pb0.05; Fig. 2B) in
deprived rats treated with saline, but treatment with lamotrigine
did not alter this decrease. However, NGF protein levels did not
alter in the prefrontal cortex (p=0.192; Fig. 2B) or the amygdala
(p=0.32; Fig. 2B).4. Discussion
Several animal models of depression have been developed. They
include models in which the “depressive behavior” is the result of
genetic selection or manipulation, or via environmental stressors
during development or in adulthood. Maternal deprivation has been
developed to study the effects of early adverse experiences on
behavior and neurobiology. In particular, maternal separation has
been proposed to represent a potential animal model of major
depression. During postnatal development, maternal separation
induces a response characterized by reduced activity and other
depressive-related behaviors (Hennessy et al., 2001). For instance,
in adult male rats that have experienced maternal separation, anti-
depressants can normalize anxiety-like behavior and endocrine
stress. Our results showed that in animals deprived, but not treated,
we obtained an increase of immobility in the forced swimming test
and administration of lamotrigine could reverse this effect. Our
results also showed a decrease in the climbing times and swimming
times in rats that were maternally deprived but not treated. These
effects in the forced swimming test were also demonstrated in
other studies which were interpreted accordingly as a depression-
like behavior (Aisa et al., 2007; El Khoury et al., 2006; Réus et al.,
2001b).
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Fig. 2. The effects of the administration of lamotrigine on animal model of depression
on the BDNF protein levels (2A) and NGF protein levels (2B) in the prefrontal cortex,
hippocampus and amygdala. Bars represent means±S.E.M. (n=10). *pb0.05
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antidepressant effects in patients with bipolar disorder (Li et al.,
2010), but it is already known that lamotrigine presents some
antidepressant-like effects. Lamotrigine has demonstrated moderate
antidepressant efﬁcacy in the treatment of bipolar and major depres-
sive disorders (Bowden et al., 1999; Calabrese et al., 2001; Calabrese
et al., 1999; Goodwin et al., 2008; Vigo and Baldessarini, 2009) with-
out signiﬁcant side-effects, such as the precipitation of mania (Hu
et al., 2010). Our ﬁndings show that lamotrigine has reversed the in-
crease in the immobility time in untreated deprived rats, an effect
that was also present in a previous study, in which lamotrigine de-
creased the immobility time in the forced swimming test (Li et al.,
2010). The forced swimming test is a measure of the animal's re-
sponse to chronic antidepressant treatments. These ﬁndings empha-
size the important antidepressant effect of lamotrigine.
Major depression is associated with reduced volumes in the hip-
pocampus and prefrontal cortex, whereas antidepressant treatments
promote several forms of neuronal plasticity, including neurogenesis,
synaptogenesis and neuronal maturation in the hippocampus (Karege
et al., 2002). Several neurotrophic factors are associated withdepression or antidepressant action. An emerging hypothesis pro-
poses that in addition to changes in neurochemical balance, problems
in information processing within speciﬁc neural networks may play a
critical role in the pathophysiology of depression (Chen et al., 2001).
Regulation of intracellular messenger cascades mediates the ability of
neuronal systems to adapt in response to pharmacological and envi-
ronmental stimuli. Antidepressants can recover plasticity within
intracellular signal transduction pathways (Duman et al., 1997;
Vaidya et al., 2007), suggesting that synaptic plasticity improvement
is a crucial event underlying antidepressant efﬁcacy.
Recent ﬁndings suggest that neurotrophin functionmight be altered
in depression. For example, decreased serum levels of brain-derived
neurotrophic factor in patients with major depression (Rao and
Rapoport, 2009) and an increased BDNF immunoreactivity in hippo-
campal BDNF in the postmortem brain of patients treated with antide-
pressants drugs (Duman, 2004) have been observed.
A potential target of lamotrigine in the brain is the arachidonic acid
signaling cascade. Chronic administration of lamotrigine markedly
down-regulates arachidonic acid signaling (Garrido et al., 2003). This
signaling pathway has been implicated in interferingwith transcription
of neuronal survival factors, and its down-regulation enhances the ex-
pression of BDNF and other neurotrophic factors in the brain (Lindsay,
1994). Studies of neurotrophic factors, particularly BDNF, have been of
particular interest and have lead to the neurotrophic hypothesis of de-
pression (Chang et al., 2009). BDNF is the most abundant neurotrophic
factor, it promotes the growth and development of immature neurons
and enhances the survival and function of adult neurons (Chung et al.,
2009).
Besides this effect, lamotrigine has an important role in the regu-
lation of signaling cascades. Consistent with another study (Bowden
et al., 1999; Chung et al., 2009), chronic treatment of lamotrigine sig-
niﬁcantly increased frontal and hippocampal BDNF protein levels in
rats, but in contrast to our ﬁndings, it demonstrated that the chronic
administration of lamotrigine reversed the decrease in BDNF levels
only in the amygdala of deprived rats. We cannot explain this discrep-
ancy, but could be related to the type of animal model and duration of
treatment. Consistent with our ﬁndings, another study showed an
increase in the expression of BDNF and its receptor, tyrosine kinase
receptor B, in the amygdala after neonatal maternal separation or ma-
ternal deprivation (Petrovich et al., 2005). In a previous study (Réus
et al., 2011b) we showed that maternal deprivation did not alter the
levels of BDNF in the hippocampus and pre-frontal cortex, but in-
creased their levels in amygdala. The amygdala, which is involved in
fear and anxiety, plays a role in feeding behavior and reward proces-
sing (Levi-Montalcini, 1987; Paton et al., 2006). Thus, it is possible
that the change in behavior may be related to differences in levels
of BDNF in the amygdala.
NGF was the ﬁrst trophic factor to be discovered as a target to regu-
late the survival and maturation of neurons (Cirulli et al., 1998) and a
series of in-depth experiments has been created to the study how the
mother-infant relationship might affect the NGF in the CNS of neonatal
rats. Our results showed a decrease in NGF levels in the hippocampus of
animals that were maternally deprived, but not treated. Contrarily to
these ﬁndings, other studies have shown an increase in NGF expression
in the hippocampus, cerebral cortex and hypothalamus in a model of
depression (Cirulli et al., 2000; Cirulli et al., 1998). In addition to this,
early maternal separation increased the NGF levels in the dorsal and
ventral hippocampus (Faure et al., 2006), suggesting that this elevation
reﬂects a compensatory mechanism. However, we have previously
shown in a similar study, that maternal deprivation reduced the NGF
levels in the hippocampus.
Treatment with lamotrigine did not reverse the levels of NGF
protein in the hippocampus of deprived rats. Furthermore, another
study has shown that chronic administration of the antidepressant
escitalopram decreased the right cortical NGF levels in chronically
stressed rats even under the untreated control conditions (Schulte-
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mood stabilizer lithium at various dosages increased NGF level in
the hippocampus, amygdala, frontal cortex, and limbic forebrain,
whereas NGF in the striatum, midbrain, and hypothalamus remained
unchanged (Hellweg et al., 2002). In a mouse model of induced
learned helplessness, after the administration of a deﬁned series of
foot shocks, stress treatment led to a transient NGF decrease in the
frontal cortex after a period of 6 h that was absent in the control
mice (Schulte-Herbrüggen et al., 2006). A similar observation was
made in rats after threatening treatment with or without painful
stimuli, which was followed by a signiﬁcant reduction of NGF protein
in the amygdala and the frontal cortex after a period of 2 h (von
Richthofen et al., 2003). In both studies, NGF returned to control
levels after a stress-dependent decrease. In addition to this, our stud-
ies showed no signiﬁcant effects in the prefrontal cortex of deprived
rats treated with saline, but showed a trend toward decreased levels
of NGF in the amygdala in the same group, as already shown in a pre-
vious study (Réus et al., 2001b) and that the maternal deprivation re-
duced the levels of NGF in the amygdala and did not signiﬁcantly alter
levels in the pre-frontal cortex of rats.
Lamotrigine has anticonvulsant action by reducing neuronal excit-
ability through the inhibition of sodium channel voltage dependents
in the inactivated state, preventing their return to a resting state
and consequently decreasing the number of action potentials. This ef-
fect on the sodium channels results in decreased glutamate release
(Leach et al., 1986; Waldmeier et al., 1996). In fact, electrophysiolog-
ical studies in the amygdala (Wang et al., 2002) and in the striatum
(Calabrese et al., 1999) showed that lamotrigine reduced excitatory
post-synaptic potential mediated by glutamate, an effect reversed
when exogenous glutamate was applied, ﬁndings consistent with
the proposal that lamotrigine had an inhibitory action on glutamate
release. Glutamate is involved in the pathogenesis and treatment of
depression. Antagonists of NMDA receptors, such as ketamine and
memantine presented antidepressant-like effects in rats, and in-
creased the BDNF levels in the hippocampus (Garcia et al., 2008a;
Réus et al., 2010, 2011a).5. Conclusion
In conclusion, treatment with lamotrigine showed antidepressant
effects in the forced swimming test and reversed the decrease in
BDNF levels in the amygdala of maternally deprived rats. The antide-
pressant effects of lamotrigine may be related, at least in part, by its
action on BDNF in the amygdala of deprived rats. It is important to
note that lamotrigine also acts on other pathways involved with
depression, such as the glutamatergic and serotoninergic systems.
With this in mind, more studies are necessary to clarify the molecular
means by which lamotrigine presents its behavior effects.Acknowledgments
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